ILSI-Biomed Israel

The Israeli Life Science Industry. 2001-2010: A DECADE of GROWTH

Following the big success of ILSI-BioMed Week: some data on Israeli Life Science industry. The Israeli Life Science Industry is young and growing. Of the existing 702 companies, 56% were founded during the last decade. A closer look reveals that a quarter (173 companies) of the Industry was established in the last five years. Figure 1 depicts the trend and growth experienced by the industry in the 2001-2010, period. 306 companies were established prior to 2001, with the oldest one, Teva Pharm...

Some photos from ILSI-Biomed

Photo credit: Ilan Levi www.ilanlevi.com More photos are available at our Facebook page. Tweet

Meet the speakers: Dalia Megiddo

Dr. Dalia Megiddo managed 2 venture capital funds: 7 Health Ventures (2006-2010) and InnoMed Ventures, since 2000. Dr Megiddo has been involved in the Life Science Venture Capital Industry since 1999 and is well recognized as one of the leaders in the healthcare investment community both in Israel and internationally. She is a frequent speaker at local and international meetings and served as a board member at Given Imaging (NASDAQ-GIVN) and Elron (NASDAQ- ELRN). She is also involved in f...

A free webinar “Medical Technology Innovation scorecard: The race for global leadership”.

ILSI is announcing a webinar by Dr. Chris Wasden titled “Medical Technology Innovation scorecard: The race for global leadership”. It will take place on January 25th at 17:00 and is free to all. If you are interested, please register through sima@ilsi.org.il or Michal@ilsi.org.il or use ILSI telephone numbers 03-600-5008/5118. Dr. Chris Wasden Dr. Christopher Wasden is a managing director leading PwC's strategy and innovation practice focused on the healthcare industry. He is a named i...

Second Webinar in the series of REIMBURSEMENT Offered by top USA Consultants and PAID BY ILSI

The US reimbursement environment is changing for medical devices and pharmaceuticals. Understanding and building plans to maximize coverage and payment across the diverse US payer landscape and gaining access to US payers is a critical hurdle for Israeli technology companies. And few ex-US technology companies are prepared for this market. Failure to prepare can – and frequently does – lead to failure to commercialize technology, or significant loss of value on exit. To help Israeli comp...

Annual Conference of Electronics&Software Industries (Israel)

Annual Conference of Electronics&Software Industries will be held at 4/1/2011 at David Intercontinental hotel. It will include a session on medical device industry. One of the speakers will be Ruti Alon, General Partner of Pitango Venture Capital, the Chairperson of ILSI and the Chairperson of ILSI-Biomed week organizing committee. Ruti Alon (Credit - Yoram Reshef) More information on http://iaesi.org.il/. Tweet

TOP USA REIMBURSEMENT GROUP OFFERING THREE WEBINARS PAID BY ILSI.

The US reimbursement environment is changing for medical devices and pharmaceuticals. Understanding and building plans to maximize coverage and payment across the diverse US payer landscape and gaining access to US payers is a critical hurdle for Israeli technology companies. And few ex-US technology companies are prepared for this market. Failure to prepare can – and frequently does – lead to failure to commercialize technology, or significant loss of value on exit. Ruti Alon (Credit - Yor...

May 23-25, 2011: save the date for ILSI-BioMed Israel!

Yes. It is about time to open your calendars and write down the next date: May 23-25 2011. ILSI-BioMed Israel 2011, that is. The 10th international Life Science & Technology Week is just around the corner. Time do flies... The event follows the highly successful 2010 BioMed conference which attracted more than 6000 participants from 51 countries. What an event! ILSI-BioMed 2011 will present high-quality program, featuring top-notch industry executives. Israel's most innovative medi...

ILSI-BioMed 2010 Has Begun!

This morning the ILSI-BioMed Week 2010 has finally been launched, with 7,000 anticipated participants that will take part in lectures and meetings with the experts and seniors of the bio-pharma and medical equipment industry in Israel and abroad. Following the opening words of the event's organizers, ILSI and Kenes, the president of Israel Shimon Peres came up to the stage and surveyed the future of Israel, which will be based on advanced technologies and serve as an example to the entire...

Israel’s Life Sciences Export On the Rise

The Coming ILSI–Biomed Israel 2010 Week: The Israel Export and International Cooperation Institute: Life Sciences Export Rose by 14% on the First Quarter of 2010, Summing up to the Total of ca. $1.7 Billion “The first 2010 quarter export of the life sciences industry summed up to ca. $1.7 billion, an increase of about 14 percent compared to the same period last year. This increase is derived from a 15.4 percent increase in the export of medications, which has summed up to ca. $1.3 Billion...